Listeriosis Diagnostics & Treatment Market Boosted by U.S. Foodborne Outbreak Surveillance | Teva Pharmaceuticals USA, Inc., Pfizer Inc., Fresenius Kabi Canada, Intelicure Lifesciences

The global Listeriosis Diagnostics & Treatment Market reached USD 465 Million in 2024 and is expected to reach USD 596 Billion by 2033, growing at a CAGR of 4.1% during the forecast period 2025-2033.

Listeriosis Diagnostics & Treatment Market Report by DataM Intelligence offers a detailed assessment of the global infectious-disease and food-safety landscape, highlighting market size, key players, and critical growth drivers. With focus on surveillance, rapid detection in food supply chains, and high-risk population management, the report delivers strategic insights for stakeholders from 2025 to 2033. In 2025 the U.S. experienced high-profile food recalls tied to Listeria monocytogenes contamination (including large retail recalls), reinforcing demand for stronger food-safety testing, cold-chain controls, and public-health responses trends that affect diagnostic and preventative market segments.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/listeriosis-market?ophp

Listeriosis Market Competitors Overview:

Teva Pharmaceuticals USA, Inc., Pfizer Inc., Fresenius Kabi Canada, Intelicure Lifesciences, Reticine Pharmaids, Aridis Pharmaceuticals Inc., Aden Healthcare, USAntibiotics, Cepham Life Sciences and Anant Pharmaceuticals Pvt. Ltd. among others.

Important Industry Updates:

On August 11, 2023, in conjunction with regional and local partners, Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) are looking into a listeria monocytogenes infection outbreak that may be related to Real Kosher Ice Cream of Brooklyn, New York's Soft Serve On The Go ice cream cups.

On May 12, 2022, following the treatment of Listeria monocytogenes-infected cells with ampicillin, researchers noticed intracellular production of antibiotic-resistant Listeria monocytogenes L-forms. The findings reported here give compelling evidence that antibiotic administration to infected host cells can cause intracellular Listeria monocytogenes to produce L-forms. Furthermore, these findings imply that intracellular L-forms remain inside host cells indicating that they represent live, still-growing, proliferating bacteria.

Methodology and Scope

The Listeriosis Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/listeriosis-market?ophp

Listeriosis Market Segments Overview:

By Type (Noninvasive Listeriosis (Febrile Listerial Gastroenteritis),Invasive Listeriosis) By Drugs (Penicillin, Ampicillin, Amoxicillin, Vancomycin, Ciprofloxacin, Azithromycin, Combination Drugs) By Route of Administration (Oral, Subcutaneous, Other) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Regional Overview for Listeriosis Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=listeriosis-market

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Listeriosis market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Listeriosis market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.